Profitability
Weight: 25%
D-
30
- 5yr Avg ROIC -40.7%
- Operating Margin Trend +16.17 pp/yr
RIGL
Rigel Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
B+
75
- 5yr Avg ROE 188.9%
- 5yr Share-Count CAGR 2.2%
Growth Quality
Weight: 25%
A
88
- 5yr Revenue CAGR 22.1%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 20%
C-
45
- 5yr FCF Margin -6.6%
- 5yr FCF/NI Conversion 0.99x
Balance Sheet
Weight: 10%
A+
94
- Net Debt / EBITDA -0.77x
- Interest Coverage (EBIT/Int) 17.64x
- Altman Z-Score 3.26
Stability
Weight: 5%
B-
64
- Negative-Revenue Years (5) 2/5
- Piotroski F-Score 6
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 1 gurus held; 1 added; 1 full exit.
- Holders
- 1
- Avg Δ position
- +21.7%
- New buys
- 0
- Full exits
- 1
- Greenblatt sold -100%
- Cooperman increased +22%